[HTML][HTML] Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis

C Gil-Cayuela, A Ortega, E Tarazón, L Martinez-Dolz… - PLoS …, 2018 - journals.plos.org
C Gil-Cayuela, A Ortega, E Tarazón, L Martinez-Dolz, J Cinca, JR González-Juanatey
PLoS One, 2018journals.plos.org
Background The association between dilated cardiomyopathy (DCM) and low thyroid
hormone (TH) levels has been previously described. In these patients abnormal thyroid
function is significantly related to impaired left ventricular (LV) function and increased risk of
death. Although TH was originally thought to be produced exclusively by the thyroid gland,
we recently reported TH biosynthesis in the human ischemic heart. Objectives Based on
these findings, we evaluated whether the genes required for TH production are also altered …
Background
The association between dilated cardiomyopathy (DCM) and low thyroid hormone (TH) levels has been previously described. In these patients abnormal thyroid function is significantly related to impaired left ventricular (LV) function and increased risk of death. Although TH was originally thought to be produced exclusively by the thyroid gland, we recently reported TH biosynthesis in the human ischemic heart.
Objectives
Based on these findings, we evaluated whether the genes required for TH production are also altered in patients with DCM.
Methods
Twenty-three LV tissue samples were obtained from patients with DCM (n = 13) undergoing heart transplantation and control donors (n = 10), and used for RNA sequencing analysis. The number of LV DCM samples was increased to 23 to determine total T4 and T3 tissue levels by ELISA.
Results
We found that all components of TH biosynthesis are expressed in human dilated heart tissue. Expression of genes encoding thyroperoxidase (–2.57-fold, P < 0.05) and dual oxidase 2 (2.64-fold, P < 0.01), the main enzymatic system of TH production, was significantly altered in patients with DCM and significantly associated with LV remodeling parameters. Thyroxine (T4) cardiac tissue levels were significantly increased (P < 0.01), whilst triiodothyronine (T3) levels were significantly diminished (P < 0.05) in the patients.
Conclusions
Expression of TH biosynthesis machinery in the heart and total tissue levels of T4 and T3, are altered in patients with DCM. Given the relevance of TH in cardiac pathology, our results provide a basis for new gene-based therapeutic strategies for treating DCM.
PLOS